Table 2 The clinicopathological features of THCA (N = 65)
From: Identification and validation of a pyroptosis-related prognostic signature for thyroid cancer
Characteristics | Samples (N = 65) | Percentage (%) |
|---|---|---|
Age | Â | Â |
 ≤ 60 | 58 | 89 |
 > 60 | 7 | 11 |
Gender | Â | Â |
 Female | 46 | 71 |
 Male | 19 | 29 |
Tumor size | Â | Â |
 < 2 cm | 42 | 65 |
 ≥ 2 cm | 23 | 35 |
Extrathyroidal invasion | Â | Â |
 Yes | 8 | 12 |
 No | 57 | 88 |
Multicentricity | Â | Â |
 Yes | 26 | 40 |
 No | 39 | 60 |
Stage | Â | Â |
 Stage I–II | 59 | 91 |
 Stage III–IV | 6 | 9 |
T | Â | Â |
 T1–2 | 44 | 68 |
 T3–4 | 21 | 32 |
N | Â | Â |
 N0 | 20 | 31 |
 N1 | 45 | 69 |